S&P 5007,623.68▼0.5% Nasdaq25,955.34▼0.2% Dow52,215.16▼1.2% Russell 2K2,775.90▼0.3% 10-Yr4.99%+4bp VIX19.45+0.42 WTI$103.44▲4.0% Gold$4,010.00▼1.2% EUR/USD1.120▼0.3% BTC$79,788▼1.6% Nikkei62,908▼2.6%
At close · Sat, Oct 24, 2026
Daily Market Updates.

US Markets

Home›US Markets›Equities›Amgen says drug combo cuts risk of death by 58% in pat…

Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer

Reported · Written up by our desk · Equities

A drug from Amgen could give patients with an aggressive form of lung cancer significantly more time to live when added to an immunotherapy from AstraZeneca.

← Newer storySaudi strikes kill 11 in Yemen as Houthi missiles target Saudi cities

More like this

US MarketsAmerican embassies tighten security as Iran threat warnings intensify ahead of U.S. midterm elections
US MarketsNoah Adams, Longtime Host of ‘All Things Considered,’ Has Died at 84
US MarketsRetail investors are not more sophisticated than 30 years ago, says former hedge fund manager
US MarketsFact vs. fiction: Doctors share whether peptides are safe and effective
US MarketsUkraine says Starlink and Starshield high speed restrictions have been lifted

Sources

CNBC MarketsAmgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.